These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2562929)

  • 1. A previously unrecognized large fraction of cytotoxic lymphocyte precursors is present in CD4+ human peripheral blood T cells.
    Kabelitz D; Brucker C; Wagner H; Fleischer B
    Cell Immunol; 1989 Feb; 118(2):285-97. PubMed ID: 2562929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis of functionally distinct human CD4+ T cell subsets.
    Rotteveel FT; Kokkelink I; van Lier RA; Kuenen B; Meager A; Miedema F; Lucas CJ
    J Exp Med; 1988 Nov; 168(5):1659-73. PubMed ID: 2903211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
    Gaugler B; Langlet C; Martin JM; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1991 Oct; 21(10):2581-9. PubMed ID: 1680703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytotoxic lymphocytes. V. Frequency and specificity of gamma delta+ cytotoxic lymphocyte precursors activated by allogeneic or autologous stimulator cells.
    Kabelitz D; Bender A; Schondelmaier S; da Silva Lobo ML; Janssen O
    J Immunol; 1990 Nov; 145(9):2827-32. PubMed ID: 2120339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+CD16-(Leu2+Leu11-) and CD16+CD3-(Leu11+Leu4-) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells.
    Kabelitz D
    Cell Immunol; 1989 Jul; 121(2):298-305. PubMed ID: 2525425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
    De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
    Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of OKT3 hybridoma cells to clonally activate CD3+ human T lymphocytes.
    Kabelitz D; Janssen O; Brucker C
    J Immunol Methods; 1988 Mar; 107(2):211-6. PubMed ID: 2964489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted cytotoxic cells in human peripheral blood lymphocytes.
    Garrido MA; Perez P; Titus JA; Valdayo MJ; Winkler DF; Barbieri SA; Wunderlich JR; Segal DM
    J Immunol; 1990 Apr; 144(8):2891-8. PubMed ID: 1691221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and proliferative allospecific T-cell clones contain perforin and mediate anti-CD3-induced cytotoxicity.
    Geisberg M; Terry LA; Flomenberg N; Dupont B
    Hum Immunol; 1992 Dec; 35(4):239-45. PubMed ID: 1293087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
    Rivas A; Koide J; Laus R; Engleman EG
    J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
    Selvan RS; Nagarkatti PS; Nagarkatti M
    Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
    Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
    Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
    Itoh K; Balch CM; Trial J; Platsoucas CD
    Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N; Heuze F; Diez E; Jotereau F
    Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.